Arch Therapeutics, Inc. (OTCMKTS:ARTH – Get Free Report)’s stock price passed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $2.06 and traded as low as $1.05. Arch Therapeutics shares last traded at $1.05, with a volume of 10,732 shares trading hands.
Arch Therapeutics Stock Performance
The business has a 50 day moving average of $2.06 and a 200-day moving average of $3.28.
Arch Therapeutics (OTCMKTS:ARTH – Get Free Report) last announced its earnings results on Tuesday, February 20th. The biotechnology company reported ($0.57) earnings per share for the quarter. The business had revenue of $0.05 million during the quarter.
Arch Therapeutics Company Profile
Arch Therapeutics, Inc, together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease.
See Also
- Five stocks we like better than Arch Therapeutics
- What Investors Need to Know to Beat the Market
- Comprehensive Analysis of PayPal Stock
- Business Services Stocks Investing
- Intuitive Surgical Stock Can Trend Much Higher This Year
- What is the Hang Seng index?
- Alibaba Stock Analysis: Insights, Trends, and Future Predictions
Receive News & Ratings for Arch Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arch Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
